Newcastle disease virus induces clathrin-mediated endocytosis to establish infection through the activation of PI3K/AKT signaling pathway by VEGFR2

被引:1
|
作者
Fan, Lei [1 ,2 ,3 ,4 ]
Xiao, Hongtao [1 ,2 ,3 ,4 ]
Ren, Jinlian [1 ,2 ,3 ,4 ]
Hou, Yuechi [1 ,2 ,3 ,4 ]
Cai, Juncheng [1 ,2 ,3 ,4 ]
Wu, Wanyan [1 ,2 ,3 ,4 ]
Xiang, Bin [5 ]
Lin, Qiuyan [1 ,2 ,3 ,4 ]
Liao, Ming [3 ,4 ,6 ]
Ren, Tao [1 ,2 ,3 ,4 ]
Chen, Libin [1 ,2 ,3 ,4 ]
机构
[1] South China Agr Univ, Coll Vet Med, Guangzhou, Peoples R China
[2] Minist Agr & Rural Affairs, Key Lab Anim Vaccine Dev, Guangzhou, Peoples R China
[3] Natl & Reg Joint Engn Lab Medicament Zoonosis Prev, Guangzhou, Peoples R China
[4] Key Lab Zoonosis Prevent & Control Guangdong Prov, Guangz?hou, Peoples R China
[5] Yunnan Agr Univ, Coll Vet Med, Kunming, Peoples R China
[6] Zhongkai Univ Agr & Engn, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Newcastle disease virus; PI3K/AKT signaling pathway; endocytosis; pathogenesis; ENTRY; PROTEIN; SUNITINIB; CANCER;
D O I
10.1128/jvi.01322-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The phosphatidyl-inositol 3-kinase/serine-threonine kinase (PI3K/ AKT) signaling pathway constitutes a classical phosphorylation cascade that integrates tyrosine, lipid, and serine acid-threonine phosphorylation, affecting cell function. The pathway is vulnerable to viral infection. Newcastle disease virus (NDV) poses a significant threat to the global poultry industry; however, its mechanism of early viral cell invasion and pathogenesis remain unclear. Previous in vivo and in vitro studies have shown that NDV infection activates PI3K/AKT signaling; however, it remains unclear whether NDV establishes infection through endocytosis regulated by this pathway. This study aimed to examine whether different genotypes of NDV strains could activate the PI3K/AKT signaling pathway within 2 h of in vitro infection. This activation, which relies on PI3K phosphorylation, remains unaffected by the phosphorylation-phosphatase and tensin homolog/phosphatase and tensin homolog (p-PTEN/PTEN) signaling pathway. Moreover, inhibition of PI3K activity impedes NDV replication. Additionally, interfering with the PI3K regulatory subunit p85 has no significant effect on NDV replication. Conversely, the tyrosine kinase activity upstream of PI3K can influence AKT activation and viral replication, particularly through vascular endothelial growth factor receptor 2 (VEGFR2). Additionally, NDV F protein primarily mediates PI3K and AKT phosphorylation to activate the PI3K/AKT signaling pathway. NDV F and VEGFR2 proteins, along with the PI3K p85 alpha subunit, interact and co-localize at the cell membrane. NDV-induced PI3K/AKT signaling pathway activation impacts clathrin-mediated endocytosis, with VEGFR2 playing a pivotal role. In conclusion, this study shows that NDV infection is established early through F protein binding to VEGFR2, activating the PI3K/AKT signaling pathway and inducing clathrin-mediated endocytosis, supporting infection prevention and control measures.IMPORTANCENewcastle disease virus (NDV) is a threat to the global poultry industry; however, the mechanisms of NDV infection remain unclear. NDV affects the phosphatidyl-inositol 3-kinase/serine-threonine kinase (PI3K/ AKT) signaling pathway, requiring endocytosis for successful infection. Based on previous studies, we identified a close correlation between NDV infection and replication and the PI3K/AKT signaling pathway activity. This study examined the molecular mechanisms through which NDV activates the PI3K/AKT signaling pathway to regulate endocytosis and facilitate infection. This study showed that early-stage in vitro NDV infection activated the PI3K/AKT signaling pathway, enhancing clathrin-mediated endocytosis, crucial for infection onset. Notably, this process involves the interaction between NDV F protein and the vascular endothelial growth factor receptor 2 tyrosine kinase, leading to the subsequent binding and phosphorylation of the PI3K p85 alpha regulatory subunit. This activation primes PI3K, initiating a cascade that promotes clathrin-mediated endocytosis. Our findings elucidate how NDV capitalizes on the PI3K/AKT signaling pathway to establish infection through endocytosis. Newcastle disease virus (NDV) is a threat to the global poultry industry; however, the mechanisms of NDV infection remain unclear. NDV affects the phosphatidyl-inositol 3-kinase/serine-threonine kinase (PI3K/ AKT) signaling pathway, requiring endocytosis for successful infection. Based on previous studies, we identified a close correlation between NDV infection and replication and the PI3K/AKT signaling pathway activity. This study examined the molecular mechanisms through which NDV activates the PI3K/AKT signaling pathway to regulate endocytosis and facilitate infection. This study showed that early-stage in vitro NDV infection activated the PI3K/AKT signaling pathway, enhancing clathrin-mediated endocytosis, crucial for infection onset. Notably, this process involves the interaction between NDV F protein and the vascular endothelial growth factor receptor 2 tyrosine kinase, leading to the subsequent binding and phosphorylation of the PI3K p85 alpha regulatory subunit. This activation primes PI3K, initiating a cascade that promotes clathrin-mediated endocytosis. Our findings elucidate how NDV capitalizes on the PI3K/AKT signaling pathway to establish infection through endocytosis.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] H2S Induces Analgesia Is Mediated In Vivo Activation of μ Opioid Receptor and PI3K/AKT Pathway Activation
    Distrutti, Eleonora
    Cipriani, Sabrina
    Renga, Barbara
    Migliorati, Marco
    Mencarelli, Andrea
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2009, 136 (05) : A98 - A98
  • [22] Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathways
    Guo, Xianqing
    Ding, Xiao
    ONCOLOGY LETTERS, 2018, 15 (06) : 9537 - 9542
  • [23] Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway
    Wang, Xian
    Jiang, Ling
    Liu, Xue-qi
    Huang, Yue-bo
    Wang, An-li
    Zeng, Han-xu
    Gao, Li
    Zhu, Qi-Jin
    Xia, Ling -ling
    Wu, Yong-gui
    PHYTOMEDICINE, 2022, 106
  • [24] Integrin β1 Mediates Vaccinia Virus Entry through Activation of PI3K/Akt Signaling
    Izmailyan, Roza
    Hsao, Jye-Chian
    Chung, Che-Sheng
    Chen, Chein-Hung
    Hsu, Paul Wei-Che
    Liao, Chung-Lin
    Chang, Wen
    JOURNAL OF VIROLOGY, 2012, 86 (12) : 6677 - 6687
  • [25] Canolol induces apoptosis in human gastric carcinoma cell through PI3K/Akt signaling pathway
    Ling Han
    Xiaoyang Xia
    Qianchun Deng
    Chang Zheng
    Zhen Zhang
    Qiqi Ji
    Xia Xiang
    Oil Crop Science, 2019, 4 (04) : 244 - 253
  • [26] Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer
    Jeyamohan, Sridharan
    Moorthy, Rajesh Kannan
    Kannan, Mahesh Kumar
    Arockiam, Antony Joseph Velanganni
    BIOTECHNOLOGY LETTERS, 2016, 38 (08) : 1251 - 1260
  • [27] The role of PI3K/Akt signaling pathway in chronic kidney disease
    Wang, Hongshuang
    Gao, Lanjun
    Zhao, Chenchen
    Fang, Fang
    Liu, Jiazhi
    Wang, Zheng
    Zhong, Yan
    Wang, Xiangting
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (08) : 2623 - 2633
  • [28] Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway
    Xiao, Zhi-ming
    Wang, Xiao-yan
    Wang, Ai-min
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2015, 62 (03) : 401 - 406
  • [29] ALK overexpression is associated with activation of PI3K/AKT signaling pathway in PTC
    Bu, Rong
    Prabhakaran, Sarita
    Beg, Shaham
    Jehan, Zeenath
    Siraj, Abdul K.
    Ahmed, Maqbool
    Hussain, Azhar
    Alsobhi, Saif A.
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2015, 75
  • [30] The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
    Yao, Hong
    Han, Xiangyang
    Han, Xiuzhen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (06) : 433 - 442